In the new review, we described the identification and the characterization of a new atypical opioid receptor with special adverse regulatory Houses to opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto often known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, can be a broad-spectrum scavenger for https://robertw680sme5.bloggazzo.com/profile